Linked Life Data

3190554

Source:http://linkedlifedata.com/resource/pubmed/id/3190554

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3190554rdf:typepubmed:Citationlld:pubmed
pubmed-article:3190554lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:3190554lifeskim:mentionsumls-concept:C0023796lld:lifeskim
pubmed-article:3190554lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:3190554lifeskim:mentionsumls-concept:C0052190lld:lifeskim
pubmed-article:3190554lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:3190554lifeskim:mentionsumls-concept:C1547548lld:lifeskim
pubmed-article:3190554pubmed:issue5lld:pubmed
pubmed-article:3190554pubmed:dateCreated1988-12-20lld:pubmed
pubmed-article:3190554pubmed:abstractTextThe C apolipoproteins are normally transferred to high density lipoproteins (HDL) after lipolysis of very low density lipoprotein (VLDL) triglyceride. In previous studies, a loss of plasma C apolipoproteins was documented after heparin-induced lipolysis in hypertriglyceridemic subjects. The present studies were designed to determine if this decline in plasma C apolipoproteins was due to their clearance with VLDL remnants. Five Type IV hypertriglyceridemic and two normal subjects were injected with 125I-VLDL and 131I-low density lipoproteins (LDL) to document kinetically an excess of VLDL apolipoprotein (apo) B flux relative to LDL apo B flux in the Type IV subjects. A mean of 46% VLDL apo B was cleared from the circulation, without conversion to intermediate density lipoprotein (IDL) or LDL. Heparin was then infused (9000 IU over 4 hours) to generate an excess of VLDL remnants that were not converted to IDL or LDL. VLDL triglyceride, apo B, and apo C concentrations fell at a similar rate. VLDL apo B declined by 42% (p less than 0.01). However, no increases were observed in IDL or LDL apo B in the Type IV subjects. This resulted in a 14% (p less than 0.01) decline in plasma apo B concentrations, indicating a clearance of VLDL remnants. VLDL apo C-II and C-III concentrations fell by 42% (p less than 0.025) and 52% (p less than 0.01), respectively. During the first 2.5 hours of infusion, they were almost quantitatively recovered in HDL. Thereafter, the C apolipoproteins declined in HDL during which time VLDL apo C concentrations continued to decline.(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:3190554pubmed:languageenglld:pubmed
pubmed-article:3190554pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:citationSubsetIMlld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3190554pubmed:statusMEDLINElld:pubmed
pubmed-article:3190554pubmed:issn0276-5047lld:pubmed
pubmed-article:3190554pubmed:authorpubmed-author:BreckenridgeW...lld:pubmed
pubmed-article:3190554pubmed:authorpubmed-author:WolfeB MBMlld:pubmed
pubmed-article:3190554pubmed:authorpubmed-author:HuffM WMWlld:pubmed
pubmed-article:3190554pubmed:authorpubmed-author:StrongW LWLlld:pubmed
pubmed-article:3190554pubmed:issnTypePrintlld:pubmed
pubmed-article:3190554pubmed:volume8lld:pubmed
pubmed-article:3190554pubmed:ownerNLMlld:pubmed
pubmed-article:3190554pubmed:authorsCompleteYlld:pubmed
pubmed-article:3190554pubmed:pagination471-9lld:pubmed
pubmed-article:3190554pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:meshHeadingpubmed-meshheading:3190554-...lld:pubmed
pubmed-article:3190554pubmed:articleTitleMetabolism of apolipoproteins C-II, C-III, and B in hypertriglyceridemic men. Changes after heparin-induced lipolysis.lld:pubmed
pubmed-article:3190554pubmed:affiliationDepartment of Medicine, University Hospital, University of Western Ontario, London, Canada.lld:pubmed
pubmed-article:3190554pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3190554pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3190554lld:pubmed